C Gridelli-Cesare

Avellino, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 102 publications

Neoadjuvant and perioperative chemo-immunotherapy in early-stage non-small cell lung cancer: international expert panel meeting by AIOT.

Neoadjuvant and perioperative chemo-immunotherapy in early-stage non-small cell lung cancer: international expert panel meeting by AIOT.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: May 23, 2026

Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study.

Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study.

Journal: Cancer treatment and research communications

Published: March 24, 2025

Immunotherapy in advanced non-small cell lung cancer: What to do for the 'Invisible' patients after IPSOS trial results?

Immunotherapy in advanced non-small cell lung cancer: What to do for the 'Invisible' patients after IPSOS trial results?

Journal: Lung cancer (Amsterdam, Netherlands)

Published: February 24, 2025

Face to face among different chemo-immunotherapy combinations in the first line treatment of patients with advanced non-small cell lung cancer: Results of an international expert panel meeting by the italian association of thoracic oncology (AIOT).

Face to face among different chemo-immunotherapy combinations in the first line treatment of patients with advanced non-small cell lung cancer: Results of an international expert panel meeting by the italian association of thoracic oncology (AIOT).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: September 26, 2023

Immunotherapy in the first-line treatment of elderly patients with advanced non-small-cell lung cancer: results of an International Experts Panel Meeting by the Italian Association of Thoracic Oncology (AIOT).

Immunotherapy in the first-line treatment of elderly patients with advanced non-small-cell lung cancer: results of an International Experts Panel Meeting by the Italian Association of Thoracic Oncology (AIOT).

Journal: ESMO open

Published: October 11, 2022

First-line immunotherapy in advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an International Expert Panel Meeting by the Italian Association of Thoracic Oncology.

First-line immunotherapy in advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an International Expert Panel Meeting by the Italian Association of Thoracic Oncology.

Journal: ESMO open

Published: October 06, 2021

First-Line Treatment of Metastatic Non-Small Cell Lung Cancer in the Elderly.

First-Line Treatment of Metastatic Non-Small Cell Lung Cancer in the Elderly.

Journal: Current oncology reports

Published: March 16, 2021

Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial.

Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial.

Journal: British journal of cancer

Published: August 13, 2019

Safety and Tolerability of Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer.

Safety and Tolerability of Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer.

Journal: Drug safety

Published: January 17, 2019

Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials.

Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: December 21, 2018

Frontline immunotherapy for NSCLC: alone or not alone?

Frontline immunotherapy for NSCLC: alone or not alone?

Journal: Nature reviews. Clinical oncology

Published: July 12, 2018

Second-Line Treatment Options in Non-Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology.

Second-Line Treatment Options in Non-Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology.

Journal: Clinical lung cancer

Published: August 02, 2017

Showing 1-12 of 102

Last Updated: 09/26/2026